What is the action of ergotamine?
Increases hypoperfusion of basilar artery vascular bed.
Decreases hypoperfusion of basilar artery vascular bed.
Increases hyperperfusion of basilar artery vascular bed.
Decreases hyperperfusion of basilar artery vascular bed.
The Correct Answer is D
Choice A rationale
Ergotamine does not increase hypoperfusion. It is used to constrict blood vessels to reduce blood flow.
Choice B rationale
Ergotamine does not decrease hypoperfusion. It is used to constrict blood vessels to reduce blood flow.
Choice C rationale
Ergotamine does not increase hyperperfusion. It is used to constrict blood vessels to reduce blood flow.
Choice D rationale
Ergotamine decreases hyperperfusion by constricting blood vessels in the basilar artery vascular bed, reducing the blood flow to relieve migraine headaches. .
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A rationale
Deoxygenated blood from the lungs would not flow to the left atrium or through the pulmonary artery.
Choice B rationale
Deoxygenated blood from the lungs would not enter the right atrium or flow through the pulmonary artery.
Choice C rationale
Oxygenated blood from the lungs does not enter the right atrium through the pulmonary veins.
Choice D rationale
Correct, oxygenated blood from the lungs enters the left atrium through the pulmonary veins.
Correct Answer is D
Explanation
Choice A rationale
This choice is incorrect. Cholinergic agonists primarily affect acetylcholine receptors, not GABA receptors. GABA receptors are involved in the inhibitory neurotransmission in the central nervous system and are the target of different drug classes, such as benzodiazepines and barbiturates, which are not related to cholinergic agonists.
Choice B rationale
This choice is incorrect. Cholinergic agonists do not decrease norepinephrine activity. Norepinephrine is a neurotransmitter involved in the sympathetic nervous system response, which is different from the cholinergic system. Drugs that decrease norepinephrine activity would have a different mechanism of action, such as adrenergic antagonists.
Choice C rationale
This choice is incorrect. The primary action of cholinergic agonists is not to increase dopamine activity. Dopamine is another neurotransmitter involved in various brain functions, including reward and motor control. Cholinergic agonists specifically target acetylcholine receptors, enhancing their activity, which is not related to dopamine receptors.
Choice D rationale
This choice is correct. Cholinergic agonists increase the activity of acetylcholine receptor sites throughout the body. These drugs mimic the action of acetylcholine, a neurotransmitter that plays a key role in the parasympathetic nervous system, which regulates functions such as muscle contraction, gland secretion, and heart rate. Enhancing acetylcholine activity helps in conditions like myasthenia gravis and certain types of glaucoma.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.